Cargando…

Desensitization: Overcoming the Immunologic Barriers to Transplantation

HLA (Human Leucocyte Antigen) sensitization is a significant barrier to successful kidney transplantation. It often translates into difficult crossmatch before transplant and increased risk of acute and chronic antibody mediated rejection after transplant. Over the last decade, several immunomodulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sethi, Supreet, Choi, Jua, Toyoda, Mieko, Vo, Ashley, Peng, Alice, Jordan, Stanley C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239985/ https://www.ncbi.nlm.nih.gov/pubmed/28127571 http://dx.doi.org/10.1155/2017/6804678

Ejemplares similares

Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients
por: Toyoda, Mieko, et al.
Publicado: (2017)

Evaluation of Clazakizumab (Anti–Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts
por: Jordan, Stanley C., et al.
Publicado: (2022)

HLA Desensitization in Solid Organ Transplantation: Anti-CD38 to Across the Immunological Barriers
por: Joher, Nizar, et al.
Publicado: (2021)

Arsenical Intolerance Overcome by Desensitization
por: Chaudhuri, R. N.
Publicado: (1936)

Advances in diagnosing and managing antibody-mediated rejection
por: Jordan, Stanley C., et al.
Publicado: (2010)

Excellent outcome after desensitization in high immunologic risk kidney transplantation
por: Lim, Jeong-Hoon, et al.
Publicado: (2019)

Donor-derived Cell-free DNA Combined With Histology Improves Prediction of Estimated Glomerular Filtration Rate Over Time in Kidney Transplant Recipients Compared With Histology Alone
por: Huang, Edmund, et al.
Publicado: (2020)

Outcomes at 3 years posttransplant in imlifidase‐desensitized kidney transplant patients
por: Kjellman, Christian, et al.
Publicado: (2021)

Immune Editing: Overcoming Immune Barriers in Stem Cell Transplantation
por: Meissner, Torsten B., et al.
Publicado: (2022)

Overcoming barriers to effective management of tardive dyskinesia
por: Caroff, Stanley N
Publicado: (2019)

Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)
por: Jordan, Stanley C., et al.
Publicado: (2021)

Oral Food Desensitization in Children With IgE-Mediated Cow's Milk Allergy: Immunological Changes Underlying Desensitization
por: Perezábad, Laura, et al.
Publicado: (2017)

Desensitization for solid organ and hematopoietic stem cell transplantation
por: Zachary, Andrea A, et al.
Publicado: (2014)

Overcome the barriers of the skin: exosome therapy
por: Yang, Gi Hoon, et al.
Publicado: (2021)

Editorial: Sensitization and Desensitization in Organ Transplantation
por: Anwar, Imran J., et al.
Publicado: (2021)

Current Desensitization Strategies in Heart Transplantation
por: Habal, Marlena V.
Publicado: (2021)

Overcoming the Cutaneous Barrier with Microemulsions
por: Lopes, Luciana B.
Publicado: (2014)

ABO-incompatible renal transplantation in developing world – crossing the immunological (and mental) barrier
por: Jha, P. K., et al.
Publicado: (2016)

Tocilizumab and Desensitization in Kidney Transplant Candidates: Personal Experience and Literature Review
por: Weinhard, Jules, et al.
Publicado: (2021)

Overcoming delivery barriers in immunotherapy for glioblastoma
por: Rui, Yuan, et al.
Publicado: (2021)

Immunotherapy of lidocaine allergy by intravenous desensitization using IFN‐gamma from a case: Overcoming impediments using IFN‐gamma during desensitization
por: Noh, Geunwoong, et al.
Publicado: (2019)

Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti‐CD20 monoclonal antibody for the desensitization of candidates for renal transplant
por: Redfield, Robert R., et al.
Publicado: (2019)

HLA Desensitization Based on Results of the Luminex Technique in Kidney Transplant – A Single-center Experience
por: Bansal, S.B., et al.
Publicado: (2021)

Molecular and Regulatory Mechanisms of Desensitization and Resensitization of GABA(A) Receptors with a Special Reference to Propofol/Barbiturate
por: Kang, Youngnam, et al.
Publicado: (2020)

Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy
por: Sethi, Supreet, et al.
Publicado: (2020)

Current Approaches to Desensitization in Solid Organ Transplantation
por: Schinstock, Carrie, et al.
Publicado: (2021)

Desensitization in transplantation: is intravenous immunoglobulin the holy grail?
por: Palsson, Ragnar, et al.
Publicado: (2022)

Engineering nanoparticles to overcome barriers to immunotherapy
por: Toy, Randall, et al.
Publicado: (2016)

Post-transplant cyclophosphamide: overcoming the HLA barrier to hematopoietic stem cell transplants
por: Bacigalupo, Andrea
Publicado: (2022)

Basic and clinical immunology – 3016. Successful desensitization to oxaliplatin for metastic colorectal carcinoma
por: Buddiga, Praveen, et al.
Publicado: (2013)

Internalization and desensitization of adenosine receptors
por: Klaasse, Elisabeth C., et al.
Publicado: (2007)

Clinical Outcomes of Perioperative Desensitization in Heart Transplant Recipients
por: Plazak, Michael E., et al.
Publicado: (2021)

Drug desensitization in allergic children
por: Silvia, Caimmi, et al.
Publicado: (2019)

Clinical practice: Drug desensitization in children
por: de Groot, Hans, et al.
Publicado: (2010)

Analysis of 4000 kidney transplantations in a single center: Across immunological barriers
por: Kwon, Hyunwook, et al.
Publicado: (2016)

Overcoming chromatin barriers
por: de Jong, Babette E, et al.
Publicado: (2019)

Tocilizumab (Anti-IL-6R) Suppressed TNFα Production by Human Monocytes in an In Vitro Model of Anti-HLA Antibody-Induced Antibody-Dependent Cellular Cytotoxicity
por: Shin, Bong-Ha, et al.
Publicado: (2017)

ABO-incompatible renal transplantation: From saline flushes to antigen-specific immunoadsorption-Tools to overcome the barrier
por: Schiffer, Mario, et al.
Publicado: (2011)

Overcoming barriers in cognitive assessment of Alzheimer's disease
por: Parra, Mario Alfredo
Publicado: (2014)

Overcoming the Blood-Brain Barrier: Functionalised Chitosan Nanocarriers
por: Caprifico, Anna E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kf67h09si7p2oq5g5rar3u6tdc